Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
Adaptive Biotechnologies (NASDAQ:ADPT) was upgraded by analysts at
Wall
Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by analysts at JPMorgan Chase & Co. from $20.00 to $21.00. They now have an "overweight" rating on the stock.
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at TD Cowen.
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock, up previously from $21.00.